Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-News
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
 Medical News
-Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory

 

 

 
NHF Represented at Blood Products Advisory Committee Meeting
 

On July 20th and 21st, NHF represented the bleeding disorders community at the Blood Products Advisory Committee (BPAC) meeting in Washington, DC.  An advisory committee of the U.S. Food and Drug Administration (FDA), BPAC reviews and evaluates data on the safety, effectiveness, and appropriate use of blood and blood products. On the agenda were updates of the most recent meetings of two other key committees, the Transmissible Spongiform Encephalopathies Advisory Committee (TSEAC) and the Advisory Committee on Blood Safety and Availability (ACBSA). 

An epidemiologist with the CDC, and a representative of the American Association of Blood Banks gave a presentation on the epidemiology and virology of the H1N1 influenza (swine flu) virus and its impact on the US blood system. Finally, CDC and FDA staff presented on new hemovigilance strategies, including a new reporting tool for hospitals to monitor adverse reactions in patients and quality control incidents associated with blood transfusions. These efforts enhance the agencies' ability to monitor the safety of blood products. The hemovigilance module of the National Healthcare Safety Network is being piloted at nine facilities across the country.

 

This section of our Web site is sponsored by: